文献速递肺外科

标准肺叶切除与袖状肺叶切除治疗非小细胞肺癌的手术结局:倾向性评分匹配分析

The surgical outcome of standard lobectomy versus sleeve lobectomy in patients with non-small cell lung cancer: propensity score matching.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2024-01-01

该回顾性研究纳入2002年1月至2020年1月间接受开胸标准肺叶切除或袖状肺叶切除的鳞癌或腺癌患者476例,其中袖状切除196例(41.1%)。经倾向性评分匹配后纳入276例(袖状组138例,标准组138例),比较术后并发症和死亡率及总生存。结果显示标准组并发症96例(69.6%) vs 袖状组92例(66.7%)(P=0.605),90天内死亡标准组3例(2.2%) vs 袖状组5例(3.6%)(P=0.723)。结论认为支气管袖状肺叶切除是安全的手术,在肿瘤学适合的病例中应用不导致高于标准肺叶切除的死亡率。

要点

  • 倾向匹配后标准组并发症96例(69.6%) vs 袖状组92例(66.7%),P=0.605。
  • 90天内死亡标准组3例(2.2%) vs 袖状组5例(3.6%),P=0.723。
  • 多因素分析显示年龄>61岁、FEV1<84%、神经周围侵犯为不良预后因素。

核心结论

  • 支气管袖状肺叶切除是安全的手术,在肿瘤学适合的病例中应用不导致高于标准肺叶切除的死亡率。

研究设计与样本

  • 回顾性分析2002年1月至2020年1月在本院接受开胸标准肺叶切除或袖状肺叶切除的鳞癌或腺癌患者,共476例,其中袖状切除196例(41.1%)。
  • 采用倾向性评分匹配比较两组,匹配变量包括年龄、合并症、T分期、N分期和病理分期,匹配后纳入276例(袖状组138例,标准组138例)。
  • 主要结局为并发症发生率和死亡率,次要结局为总生存。

主要发现

  • 多因素分析显示年龄>61岁(标准组P=0.003,袖状组P=0.005)、FEV1<84%(标准组P=0.013,袖状组P=0.205)和神经周围侵犯(标准组P=0.052,袖状组P=0.001)为各自组的不良预后因素。
  • 倾向匹配后,标准组并发症96例(69.6%) vs 袖状组92例(66.7%)(P=0.605)。
  • 倾向匹配后,90天内死亡标准组3例(2.2%) vs 袖状组5例(3.6%)(P=0.723)。

临床怎么用

  • 对于肿瘤学适合的非小细胞肺癌病例,支气管袖状肺叶切除可作为标准肺叶切除的替代选择,不增加死亡率。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The goal of this study was to compare the patients who underwent standard or sleeve lobectomy for non-small cell lung cancer in terms of postoperative outcomes, prognostic factors and overall survival. METHODS: Between January 2002 and January 2020, the patients with squamous cell carcinoma or adenocarcinoma who underwent standard lobectomy or sleeve lobectomy by thoracotomy in our clinic were analysed retrospectively. Standard and sleeve groups were compared after propensity score matching in terms of age, comorbidity, T status, N status and pathological stage. Primary outcomes were morbidity and mortality; the secondary outcome was overall survival. RESULTS: The study included 476 patients, and sleeve lobectomy was performed in 196 (41.1%) patients. Multivariable analysis revealed that age over 61 years (P = 0.003 and P = 0.005, respectively), forced expiratory volume in 1 s (FEV1) below 84% (P = 0.013 and P = 0.205, respectively) and the presence of perineural invasion (P = 0.052 and P = 0.001, respectively) were poor prognostic factors in the standard lobectomy and the sleeve groups. The propensity matching analysis included 276 patients (138 sleeve lobectomy and 138 standard lobectomy). Complications occurred in 96 (69.6%) and 92 (66.7%) patients in the standard and sleeve groups, respectively (P = 0.605). Three (2.2%) patients in the standard group and 5 (3.6%) patients in the sleeve group died within 90 days postoperatively (P = 0.723). CONCLUSIONS: Bronchial sleeve lobectomy is a safe procedure that can be applied in oncologically suitable cases without causing higher mortality than a standard lobectomy.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Ülker M, Ağkoç M, Amirov F, et al. The surgical outcome of standard lobectomy versus sleeve lobectomy in patients with non-small cell lung cancer: propensity score matching. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 39001798. doi:10.1093/icvts/ivae133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。